Globus Medical, Inc.
- Jurisdiction
United States - LEI
5299003M2P4CIK0RF205 - ISIN
US3795772082 (GMED )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
7
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Read full profile
Fundamentals
- Net revenue
€2.24B - Gross margin
59.3% - EBIT
€240.09M - EBIT margin
10.7% - Net income
€304.20M - Net margin
13.6%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
| Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
| Josh Gottheimer | May 14, 2025 | $1.00K–$15.00K |
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Buy |
| Ray Dalio |
|
|
|
Buy |
Earnings Calls
Latest earnings call: May 7, 2024 (Q1 2024)